Harmony Biosciences Holdings, Inc. HRMY In Process Research And Development Acquired
In Process Research And Development Acquired at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept hrmy:InProcessResearchAndDevelopmentAcquired.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s in process research and development acquired.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s in process research and development acquired?
- Harmony Biosciences Holdings, Inc. (HRMY) reported in process research and development acquired of $32M in Q1 2026.
- What does in process research and development acquired mean?
- This reflects the value assigned to research and development projects acquired through business combinations or asset acquisitions that have not yet reached technological feasibility. It represents a significant capital allocation toward future growth and pipeline expansion. Monitoring this helps investors assess the company's commitment to external innovation versus internal development.